These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15120315)
1. A new class of NO-donor H3-antagonists. Tosco P; Bertinaria M; Di Stilo A; Marini E; Rolando B; Sorba G; Fruttero R; Gasco A Farmaco; 2004 May; 59(5):359-71. PubMed ID: 15120315 [TBL] [Abstract][Full Text] [Related]
2. Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives. Tosco P; Bertinaria M; Di Stilo A; Cena C; Sorba G; Fruttero R; Gasco A Bioorg Med Chem; 2005 Aug; 13(15):4750-9. PubMed ID: 15946850 [TBL] [Abstract][Full Text] [Related]
3. Non-imidazole histamine NO-donor H3-antagonists. Tosco P; Bertinaria M; Di Stilo A; Cena C; Fruttero R; Gasco A Farmaco; 2005; 60(6-7):507-12. PubMed ID: 15927183 [TBL] [Abstract][Full Text] [Related]
4. [3-(1H-imidazol-4-yl)propyl]guanidines containing furoxan moieties: a new class of H3-antagonists endowed with NO-donor properties. Bertinaria M; Stilo AD; Tosco P; Sorba G; Poli E; Pozzoli C; Coruzzi G; Fruttero R; Gasco A Bioorg Med Chem; 2003 Apr; 11(7):1197-205. PubMed ID: 12628647 [TBL] [Abstract][Full Text] [Related]
5. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length. Łazewska D; Kieć-Kononowicz K; Pertz HH; Stark H; Schunack W; Elz S Pharmazie; 2001 Dec; 56(12):927-32. PubMed ID: 11802653 [TBL] [Abstract][Full Text] [Related]
6. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency. Reidemeister S; Stark H; Ligneau X; Ganellin CR; Schwartz JC; Schunack W Pharmazie; 2000 Feb; 55(2):83-6. PubMed ID: 10723763 [TBL] [Abstract][Full Text] [Related]
7. H3 receptor ligands: new imidazole H3-antagonists endowed with NO-donor properties. Bertinaria M Farmaco; 2003 Mar; 58(3):279-83. PubMed ID: 12620423 [TBL] [Abstract][Full Text] [Related]
8. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the influence of the additional ether functionality. Łazewska D; Kieć-Kononowicz K; Pertz HH; Elz S; Stark H; Schunack W Pharmazie; 2002 Dec; 57(12):791-5. PubMed ID: 12561236 [TBL] [Abstract][Full Text] [Related]
9. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain. Sadek B; Elz S; Pertz HH; Stark H; Schunack W Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060 [TBL] [Abstract][Full Text] [Related]
10. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds. Stark H; Sadek B; Krause M; Hüls A; Ligneau X; Ganellin CR; Arrang JM; Schwartz JC; Schunack W J Med Chem; 2000 Oct; 43(21):3987-94. PubMed ID: 11052804 [TBL] [Abstract][Full Text] [Related]
11. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives. Lazewska D; Kieć-Kononowicz K; Elz S; Pertz HH; Stark H; Schunack W Pharmazie; 2005 Jun; 60(6):403-10. PubMed ID: 15997826 [TBL] [Abstract][Full Text] [Related]
12. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971. Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613 [TBL] [Abstract][Full Text] [Related]
13. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds. Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain. Barocelli E; Ballabeni V; Chiavarini M; Bertoni S; Mor M; Plazzi PV; Bordi F; Impicciatore M Inflamm Res; 2000 Apr; 49 Suppl 1():S62-3. PubMed ID: 10864424 [No Abstract] [Full Text] [Related]
15. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity. Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966 [TBL] [Abstract][Full Text] [Related]
16. Search for novel leads for histamine H3-receptor antagonists: amine derivatives. Stark H; Ligneau X; Lipp R; Arrang JM; Schwartz JC; Schunack W Pharmazie; 1997 Jun; 52(6):419-23. PubMed ID: 9260265 [TBL] [Abstract][Full Text] [Related]
18. Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships. Hüls A; Purand K; Stark H; Reidemeister S; Ligneau X; Arrang JM; Schwartz JC; Schunack W Arch Pharm (Weinheim); 1996; 329(8-9):379-85. PubMed ID: 8915097 [TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists. Masłowska-Lipowicz I; Walczyński K Chem Biol Drug Des; 2014 Jan; 83(1):106-18. PubMed ID: 23957330 [TBL] [Abstract][Full Text] [Related]
20. Homologs of histamine as histamine H3 receptor antagonists: a new potent and selective H3 antagonist, 4(5)-(5-aminopentyl)-1H-imidazole. Vollinga RC; Menge WM; Leurs R; Timmerman H J Med Chem; 1995 Jan; 38(2):266-71. PubMed ID: 7830269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]